Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Kenny Valenzuela
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Pfizer’s Booster Bonanza: A Never-Ending Jabfest?

Friday, December 27, 2024 17:03
% of readers think this story is Fact. Add your two cents.


Pfizer’s Booster Bonanza: A Never-Ending Jabfest

Let me tell you, folks, the world of mRNA vaccines just got a whole lot weirder—and the “science” isn’t holding back. Harukazu Hirano and Hiroshi Asada, straight out of Japan’s health research labs, unleashed a Pandora’s box of studies on what happens after multiple rounds of Pfizer’s BNT162b2 boosters. You think the immune system is thriving after shot number four or five? Think again.

The Good, the Bad, and the Boosted

The research claims booster doses “enhance” immunity, especially for older adults who are, let’s be real, Pfizer’s cash cow. Sure, antibody levels spike after each jab—bravo, Big Pharma. But wait. Antibodies start plummeting within six months, leaving us right back where we started. What’s the plan? A booster for your booster? And another one?

These scientists also praised T-cell responses for holding the line. But let’s ask the real question: If boosters are so great, why does the immunity fade so fast? Is this planned obsolescence for the immune system, a Big Pharma dream turned dystopian reality? You bet it is.

Bivalent Boosters: A Marketing Gimmick?

Enter the so-called “bivalent boosters” designed to tackle Omicron. They claim to protect against new variants, but here’s the kicker: immunity from these miracle shots also fades. It’s like a revolving door of dependency—get a jab, feel safe for a few months, and then—bam!—back in line for another dose. Is it protection or just profit wrapped in a syringe?

Mix-and-Match Madness

Let’s talk heterologous boosters—fancy talk for mixing vaccines. According to these studies, swapping AstraZeneca for Pfizer allegedly “broadens immune responses.” But let’s not forget the untested waters we’re wading into. Where are the long-term studies? Oh, that’s right—they don’t exist. You, my friend, are the guinea pig.

The Never-Ending Jab Factory

Here’s the bottom line: Pfizer’s boosters are the gift that keeps on giving—to their shareholders. As immunity wanes, the shots keep rolling out. If this isn’t a eugenicist’s dream of perpetual population control, what is? It’s a never-ending cycle of dependency: jab, fade, repeat. And don’t even get me started on the side effects—those are swept under the rug faster than you can say “VAERS.”

This article was written by Dick Vegas, created by Kenny Valenzuela, and powered by experimentalvaccines.org. For more hard-hitting truths, visit https://experimentalvaccines.org

Related research

1. Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55
This study explores the immune responses elicited by a bivalent Omicron-adapted BNT162b2 booster in adults over 55, showing robust protection against emerging variants.
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2213082

2. Humoral and Cellular Immune Response in Elderly Residents of Long-Term Care Facilities
Examines the immunogenicity of the BNT162b2 vaccine in elderly residents, highlighting antibody titers and T cell responses.
https://www.mdpi.com/1422-0067/24/18/13728

3. Durability of Immune Response After COVID-19 Booster Vaccination
Assesses the longevity of immune responses following booster doses of the BNT162b2 vaccine in older adults, noting a gradual decline over time.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796277

4. Booster Vaccination with BNT162b2 in Children and Adolescents
Investigates the immune responses of children and adolescents after receiving the BNT162b2 booster, showing enhanced protection.
https://www.mdpi.com/2076-393X/12/8/919

5. Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 (AstraZeneca)
Explores the immune responses elicited by a BNT162b2 booster in individuals previously vaccinated with ChAdOx1.
https://www.frontiersin.org/articles/10.3389/fimmu.2022.859019/full

1. Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55

Conclusion: The bivalent booster effectively enhances immunity against both the original SARS-CoV-2 strain and Omicron BA.1. It shows a robust neutralizing antibody response, especially in individuals with prior exposure to the virus or vaccinations. This adaptation improves coverage against evolving variants.

Implications: Bivalent boosters could help mitigate the impact of emerging variants in older populations.

—

2. Humoral and Cellular Immune Response in Elderly Residents of Long-Term Care Facilities

Conclusion: Elderly residents displayed a significant, though somewhat reduced, immune response to the BNT162b2 vaccine compared to younger individuals. Cellular responses (T-cell activity) were preserved, which is crucial for long-term immunity.

Implications: Regular monitoring and potential booster doses are critical to maintaining immunity in vulnerable elderly populations.

—

3. Durability of Immune Response After COVID-19 Booster Vaccination

Conclusion: Booster doses of the BNT162b2 vaccine significantly increased both humoral (antibody-mediated) and cellular immune responses. However, antibody levels gradually waned over six months, particularly against newer variants like Omicron.

Implications: Booster doses may need to be administered periodically to sustain high levels of protection, especially in older adults.

—

4. Booster Vaccination with BNT162b2 in Children and Adolescents

Conclusion: The BNT162b2 booster significantly improved both antibody titers and cellular immunity in the pediatric population, providing enhanced protection against severe disease and transmission.

Implications: Extending booster programs to children can contribute to broader community immunity and reduce severe outcomes.

—

5. Humoral and Cellular Responses to BNT162b2 as a Booster After ChAdOx1 (AstraZeneca) Doses

Conclusion: The BNT162b2 booster elicited strong immune responses in individuals who previously received two doses of the ChAdOx1 vaccine. This included higher neutralizing antibody levels and robust T-cell responses, which were critical against variants.

Implications: Heterologous booster strategies (mixing vaccine types) are effective and should be considered in vaccination programs.

—

Overall Conclusions Across Studies

1. Booster doses of BNT162b2 are crucial for maintaining robust immune protection, particularly in older adults and high-risk groups.

2. Immune responses wane over time, necessitating periodic boosters to sustain protection, especially against emerging variants like Omicron.

3. Both humoral and cellular immunity are enhanced by booster doses, with preserved T-cell responses being critical for long-term defense.

4. Adapted boosters (e.g., bivalent formulations) demonstrate superior efficacy against specific variants, making them key tools in managing the evolving pandemic.

5. Heterologous (mix-and-match) booster regimens are effective, broadening immune responses in those initially vaccinated with other platforms like ChAdOx1.


COVID Virus or Vaccine: Neurocognitive Morbidity in Children 🧠💉

The post Pfizer’s Booster Bonanza: A Never-Ending Jabfest? first appeared on Experimental Vaccines.


Source: http://experimentalvaccines.org/2024/12/27/pfizers-booster-bonanza-a-never-ending-jabfest/?utm_source=rss&utm_medium=rss&utm_campaign=pfizers-booster-bonanza-a-never-ending-jabfest


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Click here to cancel reply.
Your Comments
Question Razz Sad Evil Exclaim Smile Redface Biggrin Surprised Eek Confused Cool LOL Mad Twisted Rolleyes Wink Idea Arrow Neutral Cry Mr. Green

Total 1 comment
  • HTLIII

    I watched my mother get sick, have her hair fall out and her skin turn scaly, then die. the new radiation treatments for cancer. God help the people who unnecessarily push this stuff on others.

    Like Dislike Report SPAM 0 Reply
MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.